Literature DB >> 29192093

8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2).

Livia Lamartina1, Giorgio Grani1, Emanuela Arvat2, Alice Nervo2, Maria Chiara Zatelli3, Roberta Rossi3, Efisio Puxeddu4, Silvia Morelli4, Massimo Torlontano5, Michela Massa5, Rocco Bellantone6, Alfredo Pontecorvi7, Teresa Montesano8, Loredana Pagano9, Lorenzo Daniele10, Laura Fugazzola11,12, Graziano Ceresini13, Rocco Bruno14, Ruth Rossetto15, Salvatore Tumino16, Marco Centanni17, Domenico Meringolo18, Maria Grazia Castagna19, Domenico Salvatore20, Antonio Nicolucci21, Giuseppe Lucisano21, Sebastiano Filetti1, Cosimo Durante1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29192093     DOI： 10.1530/ERC-17-0453

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN： 1351-0088            Impact factor:   5.678


× No keyword cloud information.
  47 in total

1.  Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-up.

Authors:  R Michael Tuttle; Ali S Alzahrani
Journal:  J Clin Endocrinol Metab       Date:  2019-03-15       Impact factor: 5.958

2.  Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?

Authors:  Tian Tian; Rui Huang; Bin Liu
Journal:  Endocrine       Date:  2019-03-28       Impact factor: 3.633

3.  TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma.

Authors:  Gustavo C Penna; Ana Pestana; José Manuel Cameselle; Denise Momesso; Fernanda Accioly de Andrade; Ana Paula Aguiar Vidal; Mario Lucio Araujo Junior; Miguel Melo; Priscila Valverde Fernandes; Rossana Corbo; Mario Vaisman; Manuel Sobrinho-Simões; Paula Soares; Fernanda Vaisman
Journal:  Endocrine       Date:  2018-06-15       Impact factor: 3.633

4.  Variations in Radioiodine Therapy in Europe: Decision-Making after Total Thyroidectomy.

Authors:  Flavio Forrer; Galina Farina Fischer; Ole Maas; Luca Giovanella; Martha Hoffmann; Ioannis Iakovou; Markus Luster; Jasna Mihailovic; Petra Petranovic Ovčariček; Alexis Vrachimis; Slimane Zerdoud; Paul Martin Putora
Journal:  Oncology       Date:  2021-11-17       Impact factor: 2.935

5.  The Updated AJCC/TNM Staging System for Papillary Thyroid Cancer (8th Edition): From the Perspective of Genomic Analysis.

Authors:  Kyubo Kim; Jin Hwan Kim; Il Seok Park; Young Soo Rho; Gee Hwan Kwon; Dong Jin Lee
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

Review 6.  Updates on the Management of Thyroid Cancer.

Authors:  Katherine A Araque; Sriram Gubbi; Joanna Klubo-Gwiezdzinska
Journal:  Horm Metab Res       Date:  2020-02-10       Impact factor: 2.936

7.  A 15 year institutional experience of well-differentiated follicular cell-derived thyroid carcinomas; impact of the new 2017 TNM and WHO Classifications of Tumors of Endocrine Organs on the epidemiological trends and pathological characteristics.

Authors:  Angela Borda; Ancuța-Elena Zahan; Doina Piciu; Elena Barbuș; Nicole Berger; Adela Nechifor-Boilă
Journal:  Endocrine       Date:  2019-12-14       Impact factor: 3.633

8.  Multi-gene assay and clinical characteristics research in papillary thyroid carcinoma.

Authors:  Chang Deng; Shan Li; Zhixin Yang; Yi Dou; Daixing Hu; Jiang Zhu; Denghui Wang; Xinliang Su
Journal:  Gland Surg       Date:  2021-01

9.  High rate of IIA/IIB neck groups involvement supports complete lateral neck dissection in thyroid carcinoma.

Authors:  Emilien Chebib; Caroline Eymerit; Nathalie Chabbert-Buffet; Bruno Angelard; Jean Lacau St Guily; Sophie Périé
Journal:  Gland Surg       Date:  2020-12

10.  Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome.

Authors:  Zhencheng Zhu; Qingzhou Zhu; Dongping Cai; Liang Chen; Weixuan Xie; Yang Bai; Kunlun Luo
Journal:  Oncol Rep       Date:  2021-04-28       Impact factor: 3.906
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.